{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:58:21Z","timestamp":1781128701432,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jiph.2017.09.021","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:52:33Z","timestamp":1507830753000},"page":"339-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014\u20132016"],"prefix":"10.1016","volume":"11","author":[{"given":"Haishaerjiang","family":"Wushouer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Fang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renagu","family":"Aishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-6685","authenticated-orcid":false,"given":"Lu-Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2017.09.021_bib0005","series-title":"Antimicrobial Resistance Global Report on Surveillance","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.jiph.2017.09.021_bib0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","article-title":"The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System","volume":"19","author":"de Kraker","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2009.06.009","article-title":"Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007","volume":"66","author":"Hoban","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2017.09.021_bib0020","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/cid\/cis1006","article-title":"Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection","volume":"56","author":"Ammerlaan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2334-12-200","article-title":"Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program","volume":"12","author":"Kuo","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2017.09.021_bib0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/AAC.01157-10","article-title":"Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections","volume":"55","author":"de Kraker","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2017.09.021_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12879-014-0590-4","article-title":"The burden of nosocomial Staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0040","series-title":"Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations","author":"Review on Antimicrobial Resistance","year":"2014"},{"issue":"6\u20137","key":"10.1016\/j.jiph.2017.09.021_bib0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijmm.2013.04.004","article-title":"Antibiotic consumption and resistance: data from Europe and Germany","volume":"303","author":"Meyer","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jiph.2017.09.021_bib0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10096-012-1795-3","article-title":"Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design","volume":"32","author":"Angebault","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0060","series-title":"Opinions of the CPC Central Committee and the State Council on Deepening the Health Care System Reform","author":"State Council of China","year":"2009"},{"key":"10.1016\/j.jiph.2017.09.021_bib0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(13)70011-2","article-title":"Legislation of clinical antibiotic use in China","volume":"13","author":"Xiao","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0070","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/jac\/dkw013","article-title":"Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6year surveillance with sales records, 2009\u201314","volume":"71","author":"Lin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2017.09.021_bib0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.micpath.2016.11.013","article-title":"Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015","volume":"103","author":"Xu","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jiph.2017.09.021_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jgar.2015.03.001","article-title":"Changes in patterns of antibiotic use in Chinese public hospitals (2005\u20132012) and a benchmark comparison with Sweden in 2012","volume":"3","author":"Sun","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiph.2017.09.021_bib0085","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.puhe.2015.02.010","article-title":"Antibiotic use in Chinese hospitals: a multicenter point-prevalence study","volume":"I29","author":"Xie","year":"2015","journal-title":"Public Health"},{"key":"10.1016\/j.jiph.2017.09.021_bib0090","series-title":"Notification on Strengthening the Clinical Application of Antibacterial Drugs and Monitoring of Bacterial Resistance","author":"National Health and Family Planning Commission of the People's Republic of China","year":"2012"},{"key":"10.1016\/j.jiph.2017.09.021_bib0095","series-title":"Statistic Yearbook of Xinjiang Uyghur Autonomous Region","author":"Statistic Bureau of Xinjiang Uyghur Autonomous Region","year":"2015"},{"key":"10.1016\/j.jiph.2017.09.021_bib0100","series-title":"Anatomical Therapeutic Chemical (ATC) classification system: guidelines for ATC classification and DDD assignment","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.jiph.2017.09.021_bib0105","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrmicro1047","article-title":"Epidemiological interpretation of antibiotic resistance studies \u2014 what are we missing?","volume":"2","author":"Schwaber","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiph.2017.09.021_bib0110","series-title":"The Administration on the clinical use of antimicrobial agents and the status quo of antimicrobial resistance in China","author":"National Health and Family Planning Commission of the People's Republic of China","year":"2016"},{"key":"10.1016\/j.jiph.2017.09.021_bib0115","series-title":"Notification on Launching National Regulatory Campaign of Clinical Application of Antibacterial Drugs","author":"National Health and Family Planning Commission of the People's Republic of China","year":"2011"},{"issue":"11","key":"10.1016\/j.jiph.2017.09.021_bib0120","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe","volume":"14","author":"van de Sande-Bruinsma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0125","series-title":"English surveillance programme for antimicrobial utilization and resistance (ESPAUR) Report 2016","author":"Public Health England","year":"2016"},{"key":"10.1016\/j.jiph.2017.09.021_bib0130","series-title":"Outpatient antibiotic prescriptions \u2014 United States","author":"Centers for Disease Control and Prevention","year":"2014"},{"issue":"9","key":"10.1016\/j.jiph.2017.09.021_bib0135","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2017.09.021_bib0140","series-title":"Surveillance of Antimicrobial Consumption in Europe 2012","author":"European Surveillance of Antimicrobial Consumption","year":"2012"},{"key":"10.1016\/j.jiph.2017.09.021_bib0145","series-title":"National Antimicrobial Therapy Guidance","author":"Department of Medical Administration and Committee of Experts on Rational Drug Use","year":"2012"},{"key":"10.1016\/j.jiph.2017.09.021_bib0150","series-title":"Notification on Implementation of \u201cGuidelines for Clinical Application of Antimicrobial Agents\u201d","author":"National Health and Family Planning Commission of the People's Republic of China","year":"2005"},{"issue":"3","key":"10.1016\/j.jiph.2017.09.021_bib0155","first-page":"3","article-title":"China antimicrobial resistance surveillance system report 2015","volume":"13","author":"Committee of Experts on Rational Drug Use","year":"2015","journal-title":"China Licensed Pharm"},{"key":"10.1016\/j.jiph.2017.09.021_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13756-015-0064-5","article-title":"Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting","volume":"4","author":"Forstner","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiph.2017.09.021_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-7-24","article-title":"Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review","volume":"7","author":"de Bruin","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2017.09.021_bib0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00313020600751069","article-title":"Antimicrobial drug utilization in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance","volume":"38","author":"Livesey","year":"2006","journal-title":"Pathology"},{"key":"10.1016\/j.jiph.2017.09.021_bib0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","article-title":"Relationships between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan","volume":"26","author":"Hsueh","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.jiph.2017.09.021_bib0180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/589333","article-title":"Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece","volume":"29","author":"Iosifidis","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.jiph.2017.09.021_bib0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3201\/eid0803.010192","article-title":"The Relationship between antimicrobial use and antimicrobial resistance in Europe","volume":"8","author":"Bronzwaer","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"Supl. 4","key":"10.1016\/j.jiph.2017.09.021_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0213-005X(13)70126-5","article-title":"Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance","volume":"31","author":"Cant\u00f3n","year":"2013","journal-title":"Enferm Infect Microbiol Clin"},{"key":"10.1016\/j.jiph.2017.09.021_bib0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2015.05.015","article-title":"Urinary Escherichia coli antimicrobial susceptibility profiles and their relationship with community antibiotic use in Tasmania, Australia","volume":"46","author":"Meumann","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jiph.2017.09.021_bib0200","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.01535-08","article-title":"Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa","volume":"53","author":"Pakyz","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034117302563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034117302563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:07:46Z","timestamp":1750939666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034117302563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1876034117302563"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2017.09.021","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014\u20132016","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2017.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Production and hosting by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}